However, previous studies have indicated that RES-induced cell death in human ovarian cancer cells is caspase-independent (17,18); the treatment of these cells with RES-BSANP resulted in the release of Cyto c and the activation of caspase-3. Here, CASP3 is linked to ovarian carcinoma.